BiotechTube

Donepezil

ApprovedCompleted
0 views this week 0 watching⚡ Active
Interest: 43/100
43
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Alzheimer's Disease

Conditions

Alzheimer's Disease

Trial Timeline

May 31, 2006 → Dec 31, 2008

NCT ID
NCT00381381

About Donepezil

Donepezil is a approved stage product being developed by Eisai for Alzheimer's Disease. The current trial status is completed. This product is registered under clinical trial identifier NCT00381381. Target conditions include Alzheimer's Disease.

What happened to similar drugs?

20 of 20 similar drugs in Alzheimer's Disease were approved

Approved (20) Terminated (2) Active (0)
✅Alfoatirin® Tab. + Aripezil® Tab. + Aripezil® Tab.YuhanApproved
✅DonepezilEisaiApproved
✅DONEPEZIL HYDROCHLORIDEEisaiApproved
✅Donepezil HCLEisaiApproved
✅Donepezil HClEisaiApproved
✅Donepezil HydrochlorideEisaiApproved
✅AriceptEisaiApproved

Hype Score Breakdown

Clinical
20
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (7)

NCT IDPhaseStatus
NCT02787746ApprovedCompleted
NCT02550665Phase 3Completed
NCT01023425Pre-clinicalCompleted
NCT00566501Phase 3Completed
NCT01023867Pre-clinicalCompleted
NCT00381381ApprovedCompleted
NCT00220896ApprovedCompleted

Competing Products

20 competing products in Alzheimer's Disease

See all competitors
ProductCompanyStageHype Score
LY450139 + PlaceboEli LillyPhase 3
40
Solanezumab + PlaceboEli LillyPhase 3
32
LY450139 dihydrate + placeboEli LillyPhase 2
35
GSK4527226AlectorPhase 2
29
GSK4527226AlectorPhase 2
32
AL002AlectorPhase 2
17
Solanezumab + PlaceboEli LillyPhase 3
32
simufilamCassava SciencesPhase 2
17
Remternetug + PlaceboEli LillyPhase 3
44
solanezumabEli LillyPhase 2
35
LY2886721 + PlaceboEli LillyPhase 1
29
Gantenerumab + Gantenerumab + Gantenerumab + PlaceboChugai PharmaceuticalPhase 1
29
Alfoatirin® Tab. + Aripezil® Tab. + Aripezil® Tab.YuhanApproved
39
FK962Astellas PharmaPhase 2
27
ASP0777 + PlaceboAstellas PharmaPhase 1
29
Elenbecestat + PlaceboEisaiPhase 3
32
DonepezilEisaiApproved
43
Aricept (donepezil SR 23 mg) + Aricept (donepezil IR 10 mg)EisaiPhase 3
40
Donepezil hydrochlorideEisaiPhase 3
40
Donepezil HydrochlorideEisaiPre-clinical
26